Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
about
The EML4-ALK oncogene: targeting an essential growth driver in human cancer.Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technologyVolumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or GefitinibNeuroblastoma treatment in the post-genomic era.New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer.Advances of small molecule targeting of kinases.Anaplastic lymphoma kinase rearrangements in non-small-cell lung cancer: novel applications in diagnostics and treatment.Lessons to be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung Cancer.Generalizing, Extending, and Maximizing Nitrogen-15 Hyperpolarization Induced by Parahydrogen in Reversible Exchange.LC-MS/MS determination of alectinib and its major human metabolite M4 in human urine: prevention of nonspecific binding.Insight into resistance mechanism of anaplastic lymphoma kinase to alectinib and JH-VIII-157-02 caused by G1202R solvent front mutation.
P2860
Q35631006-4151044A-C49C-4EA7-8F3F-4B2860B9DF90Q36303134-D1F13B2C-D76E-4E38-9186-9A71FFF03855Q36383083-E81C3A37-C79F-45B4-AECC-FB534B015743Q36553854-299F64B5-C6D1-4120-B87E-B7F28603F5BEQ37633731-5D68EE94-6C7E-4A92-9790-AB0A020F68B6Q39007500-87D8C53C-7DC1-43F7-8739-F338B0065B02Q39450797-8DF163F7-8CFB-4391-9791-6AA51364BFD8Q39459182-DFD0E73B-DDD7-4416-99D3-6C302311D419Q48231295-7C08F0C8-ABE5-4003-A02E-037C7639A105Q50923852-B9FDE2E6-5FE2-4E5B-AAEF-054D22D975B7Q51147243-DFDE6D25-8C83-46A1-9F57-A26DE05B58B3Q54978614-AE46E3F6-4254-4141-872B-3F532BF79B63
P2860
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@ast
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@en
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@nl
type
label
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@ast
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@en
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@nl
prefLabel
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@ast
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@en
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@nl
P2860
P1433
P1476
Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer.
@en
P2093
Kate McKeage
P2507
P2860
P2888
P356
10.1007/S40265-014-0329-Y
P577
2015-01-01T00:00:00Z
P6179
1036244478